State of the art in risk stratification in hypertrophic cardiomyopathy.

Back

ESC Premium Access

State of the art in risk stratification in hypertrophic cardiomyopathy.

Session: Risk stratification in hypertrophic cardiomyopathy

Topic: Cardiomyopathies

Speaker: Doctor P. Spirito (Monza, IT)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Paolo Spirito

Polyclinic - Monza C.D.C Health Centre, Monza (Italy)

1 presentation

0 follower

4 more presentations in this session

Long-term outcomes after medical therapy, alcohol septal ablation, and myectomy in patients with hypertrophic obstructive cardiomyopathy

Speaker: Doctor S. Zhai (Beijing, CN)

Association of global extracellular volume and late gadolinium enhancement with the estimated 5 year risk of sudden cardiac death according to HCM risk-SCD score in hypertrophic cardiomyopathy

Speaker: Doctor J. Muench (Hamburg, DE)

Comparison of linear versus cubic assessment of left atrial size in the prediction of atrial fibrillation development in hypertrophic cardiomyopathy

Speaker: Doctor A. Giamundo (Naples, IT)

Future direction for research in sudden death prediction in hypertrophic cardiomyopathy .

Speaker: Professor P. Elliott (London, GB)

Access

Slides

Video

Access the full session

Risk stratification in hypertrophic cardiomyopathy

Speakers: Doctor P. Spirito, Doctor S. Zhai, Doctor J. Muench, Doctor A. Giamundo, Professor P. Elliott

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources